CD8A and COVID-19: However, CD8-evading mutations described here and elsewhere62,64 have not become dominant in prevalent variants of concern so far, which may indicate that CD8 T cells exert stronger selective pressure in immunocompromised patients with defective B cell and antibody responses and chronic infection than in immunocompetent patients with a typical course of COVID-19.